Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care. It
is applicable to specialists, primary care practitioners, and providers at all levels. is Guideline should
not be considered exclusive of other methods of care reasonably directed at obtaining the same results.
e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician
aer consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
Abbreviations
ACE, angiotensin-converting enzyme; AF, atrial fibrillation; BP, blood pressure; CEA, carotid
endarterectomy; CEE, conjugated equine estrogens; COR, class of recommendation; CVD,
cardiovascular disease; CVT, cerebral venous thrombosis; ECG, electrocardiogram; HT,
hormone therapy; ICH, intracerebral hemorrhage; INR, international normalized ratio; IS,
ischemic stroke; LFT, liver function test; LMWH, low-molecular-weight heparin; LOE, level of
evidence; LVH, le ventricular hypertrophy; MI, myocardial infarction; OC, oral contraceptive;
SAH, subarachnoid hemorrhage; SBP, systolic blood pressure; TIA, transient ischemic attack;
VTE, venous thromboembolism.
Source
Bushnell C, McCullough LD, Awad IA, et al.; American Heart Association Stroke Council;
Council on Cardiovascular and Stroke Nursing ; Council on Clinical Cardiolog y; Council on
Epidemiolog y and Prevention; Council for High Blood Pressure Research. Guidelines for the
prevention of stroke in women: a statement for healthcare professionals from the American Heart
Association/American Stroke Association. Stroke. 2014;45(5):1545-1588.
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at www.GuidelineCentral.com
Copyright © 2014 All rights reserved
ASASTRWI14122
